Oliver Yoa-Pu Hu
Company: Sinew Pharma
Job title: Scientific Board Member
Seminars:
11:45 am Utilizing Non-Invasive Biomarkers, Including Blood-Based Biomarkers, to Improve MASH Diagnosis & Prognosis for Alternatives to Liver Biopsies 11:45 am
Improving MASH diagnosis using the application of non-invasive biomarkers to enhance early detection and accurate disease characterization to facilitate timely intervention and personalized treatment strategies Enhancing prognosis prediction using non-invasive biomarker analysis to more accurately assess disease progression and risk stratification to guide clinical decision-making and optimize patient management Replacing liver biopsies with non-invasive biomarker…Read more
day: Conf Day 1